These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Vaccination indications and limits in the elderly. Triglav TK; Poljak M Acta Dermatovenerol Alp Pannonica Adriat; 2013 Sep; 22(3):65-70. PubMed ID: 24089135 [TBL] [Abstract][Full Text] [Related]
4. Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014. Williams WW; Lu PJ; O'Halloran A; Kim DK; Grohskopf LA; Pilishvili T; Skoff TH; Nelson NP; Harpaz R; Markowitz LE; Rodriguez-Lainz A; Bridges CB; MMWR Surveill Summ; 2016 Feb; 65(1):1-36. PubMed ID: 26844596 [TBL] [Abstract][Full Text] [Related]
5. Immunization for the elderly. Bader MS Am J Med Sci; 2007 Dec; 334(6):481-6. PubMed ID: 18091370 [TBL] [Abstract][Full Text] [Related]
6. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials. Weston WM; Friedland LR; Wu X; Howe B Vaccine; 2012 Feb; 30(9):1721-8. PubMed ID: 22212127 [TBL] [Abstract][Full Text] [Related]
8. [Vaccination of the elderly: an update]. Carels T; Flamaing J Tijdschr Gerontol Geriatr; 2005 Nov; 36(5):203-8. PubMed ID: 16350529 [TBL] [Abstract][Full Text] [Related]
9. Update on immunizations in adults. Vaughn JA; Miller RA Am Fam Physician; 2011 Nov; 84(9):1015-20. PubMed ID: 22046942 [TBL] [Abstract][Full Text] [Related]
10. [Influenza, pneumococci, tetanus: the most important vaccinations in old age]. Nikolaus T; Baethe M MMW Fortschr Med; 2001 Nov; 143(46):39-41. PubMed ID: 11759597 [TBL] [Abstract][Full Text] [Related]
11. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006. Menzies R; Turnour C; Chiu C; McIntyre P Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998 [TBL] [Abstract][Full Text] [Related]
12. 13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety. Martinón-Torres F; Gimenez-Sanchez F; Gurtman A; Bernaola E; Diez-Domingo J; Carmona A; Sidhu M; Sarkozy DA; Gruber WC; Emini EA; Scott DA; Pediatr Infect Dis J; 2012 Apr; 31(4):392-9. PubMed ID: 22301472 [TBL] [Abstract][Full Text] [Related]
13. [Vaccination needed by over 50-year-old persons]. Plassmann E MMW Fortschr Med; 2003 Nov; 145(45):26-8. PubMed ID: 14699802 [TBL] [Abstract][Full Text] [Related]
14. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010. Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428 [TBL] [Abstract][Full Text] [Related]
16. Survey of Australian inpatients on vaccination status and perceptions of influenza vaccination. Loke XY; Tran W; Alderman CP Consult Pharm; 2012 Aug; 27(8):553-63. PubMed ID: 22910176 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of 23-valent pneumococcal polysaccharide vaccine and seasonal influenza vaccine for pneumonia among the elderly - Selection of controls in a case-control study. Kondo K; Suzuki K; Washio M; Ohfuji S; Fukushima W; Maeda A; Hirota Y; Vaccine; 2017 Aug; 35(36):4806-4810. PubMed ID: 28818473 [TBL] [Abstract][Full Text] [Related]
18. Self-reported vaccination in the elderly: SABE Bogota study, Colombia. Cano Gutierrez C; Reyes-Ortiz C; Borda MG; Arciniegas A Colomb Med (Cali); 2016 Mar; 47(1):25-30. PubMed ID: 27226661 [TBL] [Abstract][Full Text] [Related]
19. [National Survey of Vaccination Coverage (Influenza, pneumococcus and tetanus) in Mexican population of 60 years of age and older]. Trejo-Valdivia B; Mendoza-Alvarado LR; Palma-Coca O; Hernández-Ávila M; Téllez-Rojo Solís MM Salud Publica Mex; 2012; 54(1):39-46. PubMed ID: 22286827 [TBL] [Abstract][Full Text] [Related]
20. Vaccination coverage of recommended vaccines and determinants of vaccination in at-risk groups. Boey L; Bosmans E; Ferreira LB; Heyvaert N; Nelen M; Smans L; Tuerlinckx H; Roelants M; Claes K; Derdelinckx I; Janssens W; Mathieu C; Van Cleemput J; Vos R; Vandermeulen C Hum Vaccin Immunother; 2020 Sep; 16(9):2136-2143. PubMed ID: 32614656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]